Abstract
Background Early differential diagnosis of suspected pediatric patients is difficult during the 2019-nCoV epidemic.
Objective To identify clinical characteristics and key points of early differential diagnosis.
Methods A retrospective analysis was performed on suspected pediatric cases.
Results A total of 77 suspected cases were admitted from Jan 22nd to Mar 1st. Compared with non-2019-nCoV group (n=33),2019-nCoV confirmed group (n=35) had fewer fever (OR[95% CI] 0.39[0.242–0.628];P<.001) and symptoms of ARI (0.454[0.287–0.719];P<.001),more asymptomatic (15.086[2.117-107.475];P<.001), and more family cluster infections (5.469[2.405-12.433]; P<.001),while chest CT had more positive findings of viral pneumonia (1.813[1.131-2.908];P=.014).There were significant statistical differences between the two groups in age (7.2[3.9-11.4] vs 5[2.1-7.8];P=.031),body temperature (36.7[36.2-36.9] vs 37[36.7-37.9];P=.001), heart rate ([97.1±16.8] vs [109.7±15.6];P=.002),percentage ([39.4±14.9] vs [52.5±17.5]; P=.001) and count (2.25[1.43-3.53] vs 3.33[2.8-5.18];P=.007) of neutrophil, percentage (45.3[39.2-56.6] vs 33.2[22.7-42.5];P=.001) of lymphocyte,hs-CRP (5.52[1.1-9.04] vs 9.04[7.35-9.54];P=.002) and PCT (0.05[0.03-0.08] vs 0.1[0.05-0.21];P<.001),while gender (42.9% vs 57.6%;P=.332),respiratory rate (22[20-22] vs 22[20-24];P=.092),WBC (5.37[4.67-8.08] vs 6.94[5.72-8.87];P=.198), lymphocyte count (2.68[1.99-4.01] vs 2.26[1.66-2.92];P=.096),Hb (128[124-142] vs 130[119-137];P=.572) and PLT ([279.1±77.5] vs [263.4±65.1];P=.37) were statistically insignificant.
Conclusions Asymptoms or mild symptoms,positive CT findings and family cluster infection are the main clinical characteristics of infected pediatric patients. The CBC, hs-CRP and PCT can provide an important basis for early differential diagnosis. Compared with other non-bacterial infections,hs-CRP and PCT in 2019-nCoV infection are reduced,but further evidence is needed to support whether their reduction is specific.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data in this paper is true, reliable and available.
Abbreviations
- 2019-nCoV
- 2019 novel coronavirus
- CT
- computed tomography
- RT-PCR
- real-time reverse transcriptase polymerase chain reaction
- IQR
- interquartile range
- OR
- odds ratio
- CI
- confidence interval
- SD
- standard deviation
- ARI
- acute respiratory infection
- CAP
- community-acquired pneumonia
- RSV
- respiratory syncytial virus
- MP
- mycoplasma pneumoniae
- INF A,B
- influenza A,B
- CBC
- complete blood count
- WBC
- white blood cell
- N%
- percentage of neutrophil
- L%
- percentage of lymphocyte
- Hb
- Hemoglobin
- PLT
- platelet
- hs-CRP
- high sensitivity C-reactive protein
- PCT
- procalcitonin